EyePoint Pharmaceuticals, Inc. (EYPT) Financials

EYPT Assets vs Liabilities
DateAssetsLiabilities
March 31, 2026 288.2 million 57.7 million
Dec. 31, 2025 364.0 million 57.9 million
Sept. 30, 2025 251.7 million 51.5 million
June 30, 2025 301.1 million 55.1 million

EYPT Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
March 31, 2026 -81.5 million ?
Dec. 31, 2025 -66.0 million 6.7 million
Sept. 30, 2025 -60.2 million 6.4 million
June 30, 2025 -63.8 million 6.9 million

EYPT Net Income

No data available :(

EYPT Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
March 31, 2026 222.5 million - 20.2 million
Dec. 31, 2025 306.1 million - 20.8 million
Sept. 30, 2025 204.0 million - 21.3 million
June 30, 2025 255.7 million - 21.8 million

EYPT Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
March 31, 2026 86.0 million
Dec. 31, 2025 83.0 million
Sept. 30, 2025 70.2 million
June 30, 2025 69.9 million

EYPT Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
March 31, 2026 997000 72.1 million 15.2 million -
Dec. 31, 2025 986000 59.2 million 11.4 million -6000
Sept. 30, 2025 798000 47.8 million 14.5 million 26000
June 30, 2025 1.2 million 55.5 million 11.9 million 35000

EYPT Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
March 31, 2026 696000 528000
Dec. 31, 2025 620000 375000
Sept. 30, 2025 966000 721000
June 30, 2025 5.3 million 165000

EYPT Revenue by Segment
Graph available only for paid members. Upgrade to see it.

EYPT

Price: $12.08

52 week price:
7.94
19.11

Earnings Per Share: -3.51 USD

Exchange: NGM

Sector: Healthcare

Industry: Biotechnology

Country: United States

Volume: 166382

Market Capitalization: 987.7 million

Links: